The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.
Open Access
- 1 December 1992
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 11 (12) , 4313-4321
- https://doi.org/10.1002/j.1460-2075.1992.tb05530.x
Abstract
Signals delivered to B cells via CD40 can synergize with those provided by other B cell surface receptors to induce B cell proliferation and antibody class switching as well as modulate cytokine production and cell adhesion. Recently, it has been shown that the ligand for CD40 is a cell surface protein of approximately 39 kDa expressed by activated T cells, gp39. Here we report on the isolation and characterization of a cDNA clone encoding human gp39, a type II membrane protein with homology to TNF, and the construction and characterization of a soluble recombinant form of gp39. COS cell transfectants expressing gp39 synergized with either anti‐CD20 mAb or PMA to drive strong B cell proliferation and alone were able to drive B cells to proliferate weakly. In all cases the B cell proliferation induced by gp39‐expressing COS cells was reduced to background levels by the addition of soluble CD40. Unlike gp39‐expressing COS cells, recombinant soluble gp39 was not mitogenic alone and required co‐stimulation to drive B cell proliferation. These results suggest that B cells require a second signal besides gp39‐CD40 to drive proliferation and that soluble gp39 alone in a non‐membrane bound form is able to provide co‐stimulatory signals to B cells.Keywords
This publication has 44 references indexed in Scilit:
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.The Journal of Experimental Medicine, 1992
- Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen.The Journal of Experimental Medicine, 1992
- Recombinant globulins: novel research tools and possible pharmaceuticalsCurrent Opinion in Immunology, 1992
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- The establishment of monoclonal antigen-specific B-cell linesImmunology Today, 1988
- Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assayEuropean Journal of Immunology, 1987
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984